News & Updates

A recent study has found poor adherence to guideline-directed imaging surveillance (GDIS) following acute type A aortic dissection (ATAAD), as well as the persistence of substantial long-term mortality and reinterventions.

Excision of ocular surface squamous neoplasia (OSSN) with a 2-mm margin does not lead to high rates of positive surgical margins, a recent study has found. For patients who do show positive margins, adjuvant topical therapy is enough to prevent recurrence.

Increased solar activity and related geomagnetic disturbances are associated with blood pressure elevations among elderly men, a study has found.

Transarterial infusion chemotherapy with microsphere embolization is an effective treatment option for gastroesophageal junction cancer with hepatic metastasis, a recent study has found.

A multicentre study of hospitalized patients with sports- and recreational cycling–related traumatic brain injury (TBI) in Hong Kong finds cycling-related injuries carry greater risks of unfavourable outcomes and intracranial haemorrhage (ICH) vs other sports, with helmets providing significant protection against the latter.

A study using RNA sequencing of human cortical tissue and animal models reveals the role of MEF2 transcription factors in promoting cognitive resilience (CgR).

Treatment modification at the first cycle is common among elderly adults with advanced cancer, a recent study has found. Factors contributing to such a need include increasing age, lower income, and functional impairment.

Use of nintedanib in the treatment of interstitial lung disease (ILD) appears to delay its progression in Japanese patients, independent of the fibrotic pattern on high-resolution computed tomography (HRCT), as shown in a subgroup analysis of the phase III INBUILD trial.

A fractional flow reserve (FFR)-guided treatment strategy falls short of decreasing the risk of ischaemic cardiovascular (CV) events or death in patients with multivessel coronary artery disease (CAD) at 1-year follow-up, reveals a study.

The incidence of erectile dysfunction (ED) is not statistically higher in patients with rheumatoid arthritis (RA), a study has found. ED also does not increase the overall rate of cardiovascular events in RA, but it contributes to an increased risk of peripheral arterial disease (PAD) and a decreased risk of myocardial infarction (MI), heart failure (HF), and death.